Introduction {#sec1-1}
============

In recent years, the Infectious Diseases Society of America has highlighted a group of pathogens ESKAPE\[TC1\] that they currently cause the majority of hospital infections and can effectively "escape" the biocidal action of antibiotics. *Staphylococcus aureus* and *Klebsiella pneumoniae* \[TC2\]are members in this group which includes *Enterococcus faecium*, *S. aureus*, *K. pneumoniae*, *Acinetobacter baumannii*, *Pseudomonas aeruginosa*, and *Enterobacter* species ([@ref1]). The steadily increasing in multidrug-resistant bacteria to existing antibiotics is a serious problem that significantly causing treatment failure of infections and increase mortality rates ([@ref2], [@ref3]). There is an urgent need to develop new antibacterial substances or new compounds that block resistance mechanisms and improve treatment to eradicate these resistant strains. Treatment with antibacterial combinations, using two or more antibacterial agents is one of the most important strategies to overcome multidrug-resistant organism ([@ref4]).

Recently, plant antimicrobials have been found to be synergistic enhancers in that though they may not have any antimicrobial properties alone, but when they are taken concurrently with standard drugs they enhance the effect of that drug ([@ref5]-[@ref8]). There\[TC3\] are some generally accepted mechanisms of this interaction, including inhibition of protective enzymes, combination of membrane active agents, sequential inhibition of common biochemical pathways, and the use of membranotropic agents to enhance the diffusion of other antimicrobials ([@ref9]).

Phytotherapy has many potentially significant advantages associated with the synergistic interactions like, increased efficiency, reduction of undesirable effects, increase in the stability or bioavailability of the free agents and obtaining an adequate therapeutic effect with relatively small doses, when compared with a synthetic medication ([@ref10]).

During the past ten years, several reviews substantiated the effectiveness of combinations of plants with conventional antimicrobials ([@ref10]-[@ref12]). However, no studies were found that investigated the effect of combination of *Thymbra* *spicata* extract with antibiotics against multidrug (MDR) *S. aureus* and *K. pneumoniae*. *T. spicata*, (Lamiaceae), is a native plant in the flora of Syria ([@ref13]). It is an evergreen perennial Shrub that tends to grow to 0.5 m on dry, sunny hillsides and high dry meadows ([@ref14]). It is a well-known medicinal plant that used in folk medicine traditions. The essential oil found in different parts of *T. spicata* makes it an important antibacterial and antioxidant natural source. The infusion of this plant is used for treating of respiratory and sore throat infection. Besides, it used as a spice that gives a good flavor and taste to meals ([@ref15]).

It is well known that antimicrobial activities of plant extract against tested bacteria differed, depending on location ([@ref16]). So, the aim of the present study was to examine antibacterial effect of different *T. spicata* extract against multidrug- resistant strains of *S. aureus* and *K. pneumoniae* and to investigate the synergy between these extracts and commonly used antibiotics.

Materials and Methods {#sec1-2}
=====================

Bacterial strains {#sec2-1}
-----------------

Twelve different strains of *S. aureus* and *K. pneumoniae* were used to evaluate the synergetic activity of plant extracts with antibiotic including, two reference strains *S. aureus* ATCC 25923 and *K. pneumoniae* ATCC 700603. The other ten strains were clinical isolates that obtained from Aleppo University Hospital containing one sensitive strain and four multidrug-resistant for each species. Bacterial suspension was made from fresh culture and stored at -- 20 °C using 30% glycerol.

Antimicrobial agents {#sec2-2}
--------------------

Four antibiotics were used for synergism assays. These include: ampicillin, cefotaxime, amikacin and ciprofloxacin. All these antibiotics were obtained from Asia Pharmaceutical Co except ciprofloxacin, which were obtained from Obari Pharmaceutical Co.

Preparation of plant extracts {#sec2-3}
-----------------------------

Collected wild plant materials were washed with sterile water and allowed to drain and dried at 25- 30 °C in a place not exposed to sunlight and without applying any heat treatment to reduce the loss active components. Then the dried leaves were crushed to powder and kept in refrigerator at 4 °C until use. Dried, ground leaves (20 g for each extract) were extracted with 100 ml water, ethanol and petroleum ether by maceration. The extracts were filtered through a Buchner funnel with Whatman filter paper number1. After filtration, extracts were evaporated under reducing pressure to dryness at 45 °C on a rota-evaporator (B.U.C.H.I). The collected crude extracts were stored at 4 °C until using. All extracts were redissolved in dimethyl sulfoxide (DMSO 1%) with the exception of the aqueous extracts which redissolved in distilled water to 200 mg/ml. The reconstituted extract solution was sterilized by filtering through 0.45 μm membrane filter before using in bioassay ([@ref17]).

Determination of minimum inhibitory concentration (MIC) by micro -- dilution method {#sec2-4}
-----------------------------------------------------------------------------------

Minimum inhibitory concentration (MIC) of each plant extracts and antibiotics alone was determined by the micro-dilution method according to the NCCLS ([@ref18]). Serial double dilutions of the tested plant extracts, as well as the antibiotics, were prepared in Mueller-Hinton broth and transferred into a 96-well microtiter plate over the final concentration range of 0.125--128.0 µl/ml and 0.78--200 ml/ml for antibiotics and plant extracts respectively. Ten µl of working inoculum suspension was added to the wells. The final volume was 100 µl and the final bacterial concentration was 5×10^5^ CFU/ml in each well. Two controls were included, a medium with no inoculum for control of sterility, a medium with no plant extracts or antibiotics for control of inoculum viability. The plates were then incubated for 24 hr at 37 °C. After incubation, ten μl of an aqueous 0.5% triphenyl tetrazoliumchloride TTC) solution (Sigma-Aldrich) was added to each well and further incubated for 1 hr. The plates were then examined to determine a color change. Viable microorganisms interact with the TTC solution to cause a color change from no color to red. MIC was defined as the lowest concentration showing no color change which exhibited complete inhibition of growth ([@ref19]). The tests were performed in triplicate.

Evaluation of synergistic effect {#sec2-5}
--------------------------------

The checkerboard broth microdilution method was used for the determination of synergy between the antibiotics and plant extracts. Two fold serial dilutions of the antibiotic and two fold serial dilutions of the plant extracts were prepared for every combination tested and 50 μl aliquots of each component was placed into the wells of the sterile 96-well microtiter plate. The using inoculum concentration was as in MIC determination method. After incubation of microtiter plates at 37 °C for 24 hr, 10 μl of an aqueous 0.5% TTC solution was added to each well and further incubated for 1 hr. MIC was defined as the lowest concentration showing no color change which exhibited complete inhibition of growth.

The checkerboard method is often combined with calculation of fractional inhibitory concentration (FIC) index (FICI). The FIC was derived from the lowest concentration of antibiotic and plant extracts combination showing no color change of TTC. FIC value for each agent was calculated using the formula:

FICI = ΣFIC = FIC (antibiotic) + FIC (plant extract)

Where: FIC (antibiotic)= MIC of antibiotic in combination/ MIC of antibiotic alone

FIC (extract) = MIC of extract in combination/ MIC of extract alone

The interactions were classified as being synergistic for ΣFIC values of ≤0.5, additive (≥ 0.5--1.0), indifferent (≥1.0--≤4.0) or antagonistic (ΣFIC \> 4.0) ([@ref20]).

Results {#sec1-3}
=======

Antibacterial activity assay {#sec2-6}
----------------------------

This study investigated the antimicrobial activities of the phytochemicals extracted from *T. spicata* alone and in combination with four antibiotics against 6 strains of *S. aureus and* 6 strains *K*. *pneumoniae*. Antibiotic resistance profile of tested strains that presented in [Table 1](#T1){ref-type="table"} revealed that four clinical strains of *S. aureus* (Sa1-4) and four clinical strains of *K. pneumoniae* (Kp 1-4) were multidrug-resistant to tested antibiotics [Table 1](#T1){ref-type="table"}.

###### 

Antibiotics and plant extract MICs

  Bacterial strains   MIC of antibiotics µg/ml   MIC of *T. spicata* extract mg/ml                                              
  ------------------- -------------------------- ----------------------------------- ----- --- ---- --- ----- --- ------ ------ -------
  MDR Sa1             128                        R                                   32    R   16   I   32    R   50     12.5   12.5
  MDR Sa2             64                         R                                   32    R   32   R   8     R   50     12.5   12.5
  MDR Sa3             32                         R                                   16    I   16   I   16    R   25     12.5   6.25
  MDR Sa4             64                         R                                   16    I   16   I   32    R   25     6.25   6.25
  Sen. Sa5            16                         R                                   4     S   4    S   0.5   S   12.5   6.25   6.25
  Sa ATCC 25923       1                          R                                   4     S   2    S   0.5   S   25     6.25   6.25
  MDR Kp1             32                         R                                   128   R   64   R   32    R   100    100    12.5
  MDR Kp2             16                         I                                   64    R   8    I   16    R   50     50     12.5
  MDR Kp3             32                         R                                   128   R   32   R   64    R   100    50     12.5
  MDR Kp4             8                          S                                   64    R   16   I   32    R   100    50     12.5
  Sen. Kp5            4                          S                                   2     S   4    S   0.5   S   25     12.5   3.125
  Kp ATCC 700603      4                          S                                   4     S   2    S   0.5   S   50     50     25

Sa: *Staphylococcus aureus*, Kp: *Klebsiella pneumoniae*, AM: ampicillin, CEX: cefotaxime, AMK: amikacin, CIP: ciprofloxacin AQ: aquaeous, ET: ethanol, PE: petroleum ether

The MICs results of *T. spicata* water, ethanol, petroleum ether extracts showed that phytoche-micals inhibited the growth of all the bacterial strains under investigation at different extent. The extracts showed antibacterial properties that depend both on the strain and type of extract and solvent, (1% DMSO) did not inhibit the growth of tested strains. The most effective against MDR strains was petroleum ether extract as MICs ranged from 6.25 to 12.5 mg/ml for *S. aureus* strains and 12.5 mg/ml for *K. pneumoniae* strains. The aqueous extract was the least effective and MICs ranged from 25 to 50 mg/ml and 50 to 100 mg/ml for *S. aureus* and *K. pneumoniae* MDR strains respectively. The MICs of *T. spicata* extracts for ATCC and sensitive strains of *S. aureus* resemble that for MDR strains and ranged from 6.25 to 25 mg/ml, whereas the MICs of plant extracts for ATCC and sensitive strains of *K. pneumoniae* were slightly less than that for MDR strains and ranged from 3.12 to 100 mg/ml.

Evaluation of synergistic effect of antibiotics/extract {#sec2-7}
-------------------------------------------------------

The combination of ampicillin, cefotaxime and amikacin plus plant extracts have synergistic effects on all studied strains of *S. aureus*. Whereas, the joint activity of ciprofloxacin with plant extract showed mostly additive and indifferent effect. The best synergistic capacity against *S. aureus* strains appeared with cefotaxime followed by ampicillin. The interaction between plant extracts was better for resistant strains than sensitive strains as the FIC indices of cefotaxime /antibiotic combination for example were ranged for resistant strains (0.02 to 0.26) comparing with (0.19 to 0.38) for sensitive strains.

The results of a combination of plant extracts against *K. pneumoniae* strains were less effective than against *S. aureus* strains as the most combinations exhibited indifferent effect. The best synergistic capacity against *K. pneumoniae* strains appeared with ampicillin and the FIC indices were ranged from 0.25 to 0.5 for resistant strains. However, with sensitive strains ampicillin-plant extracts mixture showed additive reaction [Table 3](#T2 T3){ref-type="table"}. Cefotaxime showed synergism with all *T. spicata* extracts for MDR Kp1 and Kp2 and additive effect for the other strains. Ethanol extract in contrast to other extracts was found to be synergistically effective in combination with amikacin against MDR Kp1 and ATCC KP. Ciprofloxacin has additive and indifference effect with resistant and sensitive *K. pneumoniae* strains when combined with all *T. spicata* extracts.

###### 

FICs of *S. aureus* strains for the antibiotics/*Thymbra spicata* extract combinations

  *S. aureus* strains   FICs       AM         CTX        AMK        CIP                                                                         
  --------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------ ------ ------ ------
                        FIC (Ab)   0.06       0.01       0.02       0.002      0.01       0.06       0.03       0.06       0.03   0.5    0.25   0.25
  MDR Sa1               FIC (Ts)   0.06       0.06       1.25       0.02       0.06       0.06       0.06       1.13       0.06   0.5    0.5    0.5
  ΣFIC                  **0.12**   **0.07**   **0.27**   **0.02**   **0.07**   **0.12**   **0.09**   **0.18**   **0.09**   1      0.75   0.75   
  FIC (Ab)              0.13       0.03       0.03       0.06       0.06       0.06       0.06       0.03       0.06       1      0.13   0.13   
  MDR Sa2               FIC (Ts)   0.13       0.13       0.13       0.06       0.06       0.06       0.13       0.13       0.13   0.25   0.5    0.5
  ΣFIC                  **0.26**   **0.16**   **0.16**   **0.12**   **0.12**   **0.12**   **0.19**   **0.16**   **0.19**   1.25   0.63   0.63   
  FIC (Ab)              0.25       0.13       0.13       0.13       0.06       0.06       0.13       0.06       0.25       0.25   0.25   0.25   
  MDR Sa3               FIC (Ts)   0.13       0.13       0.13       0.13       0.06       0.13       0.06       0.13       0.06   0.75   0.5    1
  ΣFIC                  **0.38**   **0.26**   **0.26**   **0.26**   **0.12**   **0.19**   **0.19**   **0.19**   **0.31**   0.75   0.75   1.25   
  FIC (Ab)              0.06       0.13       0.25       0.13       0.13       0.13       0.13       0.13       0.13       0.25   0.13   0.13   
  MDR Sa4               FIC (Ts)   0.06       0.25       0.13       0.13       0.13       0.13       0.13       0.25       0.25   0.5    0.5    0.5
  ΣFIC                  **0.12**   **0.38**   **0.38**   **0.26**   **0.26**   **0.26**   **0.26**   **0.38**   **0.38**   0.75   0.63   0.63   
  FIC (Ab)              0.13       0.06       0.13       0.13       0.03       0.06       0.25       0.13       0.13       1      0.5    0.25   
  Sen. Sa5              FIC (Ts)   0.5        0.25       0.13       0.25       0.25       0.13       0.13       0.13       1.13   0.12   0.25   0.5
  ΣFIC                  0.63       **0.31**   **0.26**   **0.38**   **0.28**   **0.19**   **0.38**   **0.26**   **0.26**   1.12   0.75   0.75   
  FIC (Ab)              0.25       0.13       0.25       0.13       0.06       0.13       0.25       0.13       0.13       1      0.5    1      
  ATCC 25923            FIC (Ts)   0.25       0.13       0.5        0.13       0.13       0.13       0.25       0.25       0.25   0.25   0.5    0.5
  ΣFIC                  **0.5**    **0.26**   0.75       **0.26**   **0.19**   **0.26**   **0.5**    **0.38**   **0.38**   1.25   1      1.5    

Sa: *Staphylococcus aureus*, Kp: *Klebsiella pneumoniae*, AM: ampicillin, CEX: cefotaxime, AMK: amikacin, CIP: ciprofloxacin AQ: aquaeous, ET: Ethanol, PE: petroleum ether

###### 

FICs of *K. pneumoniae* strains for the antibiotics/*Thymbra spicata* extract combinations

  *K.pneumoniae* strains   FICs       AM         CTX        AMK       CIP                                                                
  ------------------------ ---------- ---------- ---------- --------- ---------- ---------- ------ --------- ------ ------ ------ ------ ------
  MDR Kp1                  FIC (Ab)   0.25       0.13       0.13      0.25       0.13       0.13   0.25      0.25   0.13   0.5    0.5    0.25
  FIC (Ts)                 0.25       0.13       0.25       0.25      0.13       0.25       0.5    0.25      0.5    0.5    0.5    1      
  ΣFIC                     **0.5**    **0.26**   **0.38**   **0.5**   **0.26**   **0.38**   0.75   **0.5**   0.63   1      1      1.25   
  MDR Kp2                  FIC (Ab)   0.25       0.13       0.13      0.25       0.13       0.13   0.5       0.25   0.25   1      0.25   0.25
  FIC (Ts)                 0.25       0.13       0.13       0.25      0.25       0.25       0.5    0.5       1      1      0.5    0.5    
  ΣFIC                     **0.5**    **0.26**   **0.26**   **0.5**   **0.38**   **0.38**   1      0.75      1.25   1.5    0.75   0.75   
  MDR Kp3                  FIC (Ab)   0.5        0.25       0.25      0.25       0.13       0.13   0.25      0.25   0.13   0.5    0.25   0.13
  FIC (Ts)                 0.25       0.25       0.25       0.5       0\. 5      0.5        1      1         1      1      0.5    1      
  ΣFIC                     0.75       **0.5**    **0.5**    0.75      0.63       0.63       1.25   1.25      1.13   1.5    0.75   1.13   
  MDR Kp4                  FIC (Ab)   0.25       0.13       0.13      0.25       0.13       0.13   0.5       0.5    0.25   0.5    0.25   0.25
  FIC (Ts)                 0.25       0.13       0.5        0.5       0.25       0.5        0.5    1         0.5    1      1      1      
  ΣFIC                     **0.5**    **0.26**   0.63       0.75      **0.38**   0.63       1      1.5       0.75   1.5    1.25   1.25   
  Sen. Kp5                 FIC (Ab)   0.5        0.5        0.5       0.5        0.25       0.25   0.5       0.5    0.25   1      1      1
  FIC (Ts)                 0.5        0.5        1          0.5       0.5        1          0.5    0.5       1      1      1      1      
  ΣFIC                     1          1          1.5        1         0.75       1.25       1      1         1.25   2      2      2      
  ATCC 700603              FIC (Ab)   0.25       0.25       0.25      0.25       0.25       0.25   0.5       0.25   0.25   1      1      1
  FIC (Ts)                 0.5        0.5        0.5        1         0.5        0.5        1      0.25      1      1      1      1      
  ΣFIC                     0.75       0.75       0.75       1.25      0.75       0.75       1.5    **0.5**   1.25   2      2      2      

Sa: *Staphylococcus aureus*, Kp: *Klebsiella pneumoniae*, AM: ampicillin, CEX: cefotaxime, AMK: amikacin, CIP: ciprofloxacin, AQ: aquaeous, ET: ethanol, PE: petroleum ether

Among plant extracts, ethanol extract demonstrated best results with different tested antibiotic. Ethanol extract exhibited synergy with ampicillin for ten of twelve strains. cefotaxime/ ethanol extract and amikacin/ ethanol extract showed synergism with nine and eight of tested strains respectively. The mean FIC indices for combinations of ampicillin with aqueous or petroleum ether extracts were from 0.12 to 0.75 and 0.16 to 0.75 respectively.

Discussion {#sec1-4}
==========

*S. aureus* is recognized as one of the major causes of infections in humans occurring in both the community and the hospital. Multidrug- resistant staphylococci have become a major nosocomial pathogen; infections are very difficult to cure because strains are resistance against almost all clinically available antibiotics ([@ref21]).

In addition, *K. pneumoniae* is a frequent cause of nosocomial infections and has also emerged as an agent of severe community-acquired infections, including pyogenic liver abscess, pneumonia, and meningitis ([@ref22]). Antimicrobial drugs effective for treatment of infection with MDR bacteria are limited. Thus, it is valuable to find compounds that potentiate antimicrobial activity of antibiotics on these bacteria. The ability of plant extracts to act synergistically with antibiotics is considered a new approach that helps in solving the problem of bacterial resistance ([@ref5], [@ref10], [@ref23]).

In current study, the MIC of plant extracts against MDR *S. aureus* and *K. pneumoniae* strains ranged from 6.25 to 50 and 12.5 to 100 mg/ml respectively, which reflects a moderate antibacterial effect against studied strains. These findings are consistent with those obtained in some previous studies to a certain degree considering the antibacterial effect of the essential oils of *T. spicata* ([@ref24]-[@ref26]). Nevertheless, the antibacterial effect of the water, ethanol and petroleum ether extracts of *T. spicata* was seldom evaluated against MDR *S. aureus* and *K. pneumoniae* clinical isolates and most previous studies on the antibacterial activity of *T. spicata* were on its essential oils. The MICs values of plant extracts against sensitive and resistant strains were convergent. It was reported that bacterial strain in the same species that are sensitive to antibiotics, exhibit higher sensitivity to plant extracts than resistant ([@ref27], [@ref28]). This may be due to the difference in modes of action of various compounds present in the extracts, to which the organism was never exposed before and hence never had a chance to develop resistance. The antimicrobial properties of alcoholic and petroleum ether extract were superior compared to aqueous extract for those selected bacteria. This finding was in accordance with previous research which had reported that the plant extracts using organic solvent exhibited more antibacterial activity compared to the extract using aqueous as a solvent ([@ref29]).

The antibacterial effect of *T. spicata* extracts was more evident against *S. aureus* strains than *K*. *pneumoniae* strains. Similar to current study, Omar *et al* (2013) reported that *S. aureus* and *K. pneumoniae* were sensitive to aqueous extract of *T. spicata* (MIC= 50 mg/ml) but *K. pneumoniae* was resistant to ethanolic extract ([@ref30]). In addition, Bakhtiyari *et al* (2014) found Gram-negative bacteria to be less susceptible to hydroalcoholic extract and essential oil of *T. spicata* than Gram-positive bacteria ([@ref31]). This difference could be explained by the presence of an outer membrane in Gram negative bacteria, the lipopolysacharide layer that hindered the access of most compounds to the bacterial cell ([@ref32]).

Although the antibacterial activity *T. spicata* is reported ([@ref24]-[@ref26]) the amount of data published about its effectiveness against multidrug-resistant pathogens is very scanty. Consequently, the present study was focused on the antibacterial as well as synergistic activity of plant extracts with antibiotics. The results revealed the synergistic and additive interactions between *T. spicata* phytochemicals and antibiotics, which are cell wall inhibitors (ampicillin, cefotaxime), protein synthesis inhibitor (amikacin), and DNA synthesis inhibitor (ciprofloxacin). Beta-lactam antibiotics were one of the antimicrobial groups that most commonly associated with a positive interaction potential, which was also approved in this current study ([@ref33]-[@ref35]). The major mechanism of β-lactam resistance has involved β-lactamases and altered penicillin binding proteins (PBPs) ([@ref36], [@ref37]).

The exact mechanism for the reduction of β-lactam resistance by the natural antimicrobials is unknown but it maybe due to some structural change in the resistant bacteria, inhibition of the activity of penicillinase ([@ref37]) or inhibition of the activity of altered PBP production ([@ref38]). The resistance to aminoglycoside is caused by three mechanisms: reduced uptake or decrease permeability, alteration at ribosomal binding sites, or production of modifying enzymes ([@ref39]). The combination of amikacin with *T. spicata* extracts resulted in synergistic activity when tested against all *S. aureus* strains. However, ethanolic extract showed synergism with amikacin against only two strains (ATCC and MDR Kp1) of *K. pneumoniae* where the activity of amikacin increase four fold. The difference between two species may explained by different type of resistance mechanisms.

As in the present study, Atteiaa and Husseinb (2014) noticed better synergism between ethanolic extract from *Syzygium aromaticum* (clove) and *Allium sativum* (garlic) with different used antibiotics comparing with water extract against *S. auerus* and *K. pneumoniae* isolates ([@ref40]). However, the combination between antibiotics and extracts was tested by disk-diffusion method and synergistic effect was observed on the basis of enlargement of inhibition zone.

Nucleic acid synthesis inhibitor commonly showed indifference effect with all extracts and against all studied strains. Ciprofloxacin and ofloxacin were reported to have a good synergistic activity with different phytochemical compound in previous studies which contraindicated with our results ([@ref35], [@ref41]). However, different other study reported none or weak synergism activity between nucleic acid synthesis inhibitor and plant extracts ([@ref33], [@ref41]).

The MICs of antibiotics against studied MDR strains demonstrated high level of resistance to common antibiotics. All the extracts of the studied plant showed an increase in the antimicrobial activity of certain drugs that can be used against *S. aureus* or *K. pneumoniae*. The average increase in activity of antibiotic against resistant *S. aureus* ranged from 8-128 fold for cefotaxime and from 4-16 fold for amikacin.

The average increase in activity of antibiotic against resistant *K. pneumoniae* ranged from 4-8 fold for ampicillin, cefotaxime and amikacin. The synergistic effect between antimicrobial agent and plant extracts was occurred in both sensitive and resistant strains, but the MIC was decreased more in resistant than sensitive strains. The average increase in activity of antibiotic against sensitive strains ranged from 2-16 fold for *S. aureus* and 2 fold for *K. pneumoniae*. It was reported that combination of two agents exhibit significant synergism only if the test organism is resistant to at least one of the agents ([@ref43], [@ref44]). The current study findings are consistent with previous reports which showed that some plant extracts can increase the activity of antimicrobial drugs *in vitro* against bacteria ([@ref24], [@ref33], [@ref45]-[@ref48]). The synergistic interaction observed between *T. spicata* extracts and the evaluated antibiotics can be translated into useful clinical applications in *S. aureus* and *K. pneumoniae* infections. Essential oil is one of the main compounds of this herb which exists in 1-2%. It's characterized by a high content of carvacrol, γ-terpinene and *p*-cymene ([@ref14], [@ref15], [@ref24]). The synergistic activity of *T.spicata* extracts may attribute to ability of active component like carvacrol to disturb the cell wall and depolarize the cytoplasmic membrane and then facilitate the influx of antibiotics inside bacterial cell ([@ref48], 49).

The combinations of antibiotics with plant extracts could be a significant basis for development of new approach in resistance modifying agents because the use of extracts shows a low risk of increasing bacterial resistance to their action. Actually, the extracts contain mixtures of different bioactive compounds, which make microbial adaptability very difficult comparing to single-constituent antibiotics ([@ref12]).

Conclusion {#sec1-5}
==========

*T. spicata* extracts are found to have the capability of increasing the susceptibility of the studied strains to various antibiotics. The present study clearly suggests the possibility of use of the above shown synergistic drug-herb combinations for combating infections caused by MDR strains.
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